安普克
癌症研究
细胞生物学
SIRT2
化学
基因沉默
小发夹RNA
信号转导
肌肉肥大
内科学
内分泌学
氧化应激
心肌细胞
病态的
再灌注损伤
自噬
心脏纤维化
下调和上调
缺血
小干扰RNA
心肌肥大
基因敲除
脱氮酶
医学
药理学
细胞生长
心理压抑
纤维化
AMP活化蛋白激酶
作者
Liqin Zhuang,Jun Xiong,吴志坚,Huihong Zeng,Yuanping Cao,Xia Yan,Yanqing Wu,Jinying Tong
标识
DOI:10.1097/fjc.0000000000001890
摘要
Cardiac hypertrophy, a response to pathological stimuli, eventually progresses to heart failure. Ovarian tumor-associated proteinase B1 (OTUB1), a deubiquitinase of the ovarian tumor (OUT) family, regulates inflammation, cell survival, and oxidative stress in various diseases, but its role in cardiac hypertrophy remains unclear. Here, we investigated OTUB1 expression, function, and mechanism in pathological cardiac hypertrophy. OTUB1 expression was significantly downregulated in human hypertrophic hearts, transverse aortic constriction (TAC)-induced mouse hypertrophic hearts, and phenylephrine-stimulated neonatal rat ventricular myocytes (NRVMs). OTUB1 knockout (KO) mice exhibited exacerbated TAC-induced cardiac hypertrophy, dysfunction, and fetal gene reactivation, whereas OTUB1 overexpression attenuated PE-induced cardiomyocyte enlargement. Mechanistically, OTUB1 directly bound to, deubiquitinated, and stabilized Sirt2, thereby promoting AMPK phosphorylation. Silencing Sirt2 abolished the anti-hypertrophic effects of OTUB1 and blocked AMPK activation. In conclusion, OTUB1 protects against pathological cardiac hypertrophy by stabilizing Sirt2 and activating the AMPK signaling pathway, suggesting that OTUB1 is a promising therapeutic target for hypertrophy-associated heart failure.
科研通智能强力驱动
Strongly Powered by AbleSci AI